These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies. Sousa E; Isenberg D Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785 [TBL] [Abstract][Full Text] [Related]
3. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents. Dooley MA; Ginzler EM Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823 [TBL] [Abstract][Full Text] [Related]
4. New treatments for SLE: cell-depleting and anti-cytokine therapies. Anolik JH; Aringer M Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407 [TBL] [Abstract][Full Text] [Related]
5. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases]. Szegedi G Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537 [TBL] [Abstract][Full Text] [Related]
6. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events. Murdaca G; Colombo BM; Puppo F Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271 [TBL] [Abstract][Full Text] [Related]
7. Update on emerging drug therapies for systemic lupus erythematosus. Mok CC Expert Opin Emerg Drugs; 2010 Mar; 15(1):53-70. PubMed ID: 20148712 [TBL] [Abstract][Full Text] [Related]
8. Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system. Kirou KA; Salmon JE; Crow MK Rheum Dis Clin North Am; 2006 Feb; 32(1):103-19, ix. PubMed ID: 16504824 [TBL] [Abstract][Full Text] [Related]
9. B cells in SLE: different biological drugs for different pathogenic mechanisms. Diamanti AP; Rosado MM; Carsetti R; Valesini G Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325 [TBL] [Abstract][Full Text] [Related]
10. Trials and tribulations in systemic lupus erythematosus. Wofsky D Bull NYU Hosp Jt Dis; 2010; 68(3):175-8. PubMed ID: 20969548 [TBL] [Abstract][Full Text] [Related]
11. Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not! Karim MY; Pisoni CN; Khamashta MA Rheumatology (Oxford); 2009 Apr; 48(4):332-41. PubMed ID: 19155279 [TBL] [Abstract][Full Text] [Related]
12. Biologics in SLE: the current status. Rajadhyaksha AG; Mehra S; Nadkar MY J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965 [TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in children: current and emerging therapies. Macdermott EJ; Adams A; Lehman TJ Lupus; 2007; 16(8):677-83. PubMed ID: 17711907 [TBL] [Abstract][Full Text] [Related]
17. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Lo MS; Tsokos GC Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448 [TBL] [Abstract][Full Text] [Related]
18. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy. Driver CB; Ishimori M; Weisman MH Ann Rheum Dis; 2008 Oct; 67(10):1374-81. PubMed ID: 17720723 [TBL] [Abstract][Full Text] [Related]
19. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943 [TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus: modern strategies for management: a moving target. King JK; Hahn BH Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):971-87. PubMed ID: 18068856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]